Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Turning Back the Clock on Adult Stem Cell Aging

By BiotechDaily International staff writers
Posted on 03 Oct 2011
Print article
Researchers have demonstrated they can reverse the aging process for human adult stem cells, which are responsible for helping old or damaged tissues regenerate. The study’s results could lead to medical treatments that may repair a variety of disorders that occur because of tissue damage as people age.

A research group led by the Buck Institute for Research on Aging (Novato, CA, USA) and the Georgia Institute of Technology (Atlanta, GA, USA conducted the study in cell culture, which was published in the September 1, 2011, edition of the journal Cell Cycle.

The regenerative capability of tissues and organs declines as people age. The modern day stem cell theory of aging suggests that living organisms are as old as are its tissue specific or adult stem cells. Therefore, an understanding of the molecules and processes that enable human adult stem cells to trigger self-renewal and to divide, proliferate, and then differentiate in order to rejuvenate damaged tissue might be the answer to regenerative medicine and an ultimate cure for many age-related diseases. A research group led by the Buck Institute for Research on Aging in collaboration with the Georgia Institute of Technology conducted the study that identifies what is going wrong with the biologic clock underlying the limited division of human adult stem cells as they age.

“We demonstrated that we were able to reverse the process of aging for human adult stem cells by intervening with the activity of non-protein coding RNAs originated from genomic regions once dismissed as nonfunctional ‘genomic junk,’” said Victoria Lunyak, associate professor at the Buck Institute for Research on Aging.

Related Links:
Buck Institute for Research on Aging
Georgia Institute of Technology



Print article

Channels

Drug Discovery

view channel
Image: A scanning electron microscope (SEM) image of methicillin-resistant Staphylococcus aureus bacteria (Photo courtesy of the CDC).

Drug Combination Cures MRSA Infection While Preventing Development of Resistance

Treatment with a combination comprising the well-known antibiotic cefdinir and the experimental drug TXA709 cured mice of drug-resistant staphylococcal infections while reducing the development of resistance.... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.